BSE filing, NSE: BAMPSL. Summary written from the filing by ALFA Finder's alert engine.
Bampsl Securities Ltd: key numbers
- Share price
- ₹18.30
- Market cap
- ₹62.28 Cr
- Revenue (annual)
- ₹25.22 Cr
- Net profit (annual)
- ₹0.40 Cr
- P/E (TTM)
- 158.4×Sector 19.7×
- Promoter holding
- 10.83%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bampsl Securities Ltd
All →Bampsl Securities Other Announcement
The company submitted its quarterly Regulation 74(5) compliance certificate for the period ending September 30, 2026, confirming the dematerialization of physical share certificates.
Bampsl Securities Annual General Meeting
Bampsl Securities Limited held its 31st Annual General Meeting, where it passed resolutions to adopt financial statements and re-appoint directors.
Bampsl Securities Annual Report
Bampsl Securities Ltd has released its 31st Annual Report for the 2025-2026 financial year. The company's Annual General Meeting is scheduled for September 29, 2026.
Bampsl Securities Board Meeting Outcome
Bampsl Securities Ltd approved the notice of the Annual General Meeting and appointed a scrutinizer in its board meeting held on August 25, 2026.
Bampsl Securities Board Meeting Date
Bampsl Securities Ltd has scheduled a Board Meeting on August 25, 2026, to discuss the Annual General Meeting notice, date, and appointment of scrutinizers.
Bampsl Securities Q1 FY27 Results: Net Profit ₹0.5 Cr, Up 0.0% YoY
Bampsl Securities Ltd reported revenue from operations of ₹3.6 Cr (-58.6% YoY) and net profit of ₹0.5 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.5 Cr · +0.0% YoY
Other board meeting date announcements
All →Indowind Energy Board Meeting Date
Indowind Energy scheduled a board meeting on 5 Nov 2026 to approve Q1 FY27 unaudited results. The trading window remains closed until 48 hours post-approval.
Dhunseri Ventures Board Meeting Date
Dhunseri Ventures Ltd intimated that its Board will meet on 6 November 2026, inter alia to approve Q2 FY27 results. The trading window stays closed until 8 November 2026.
CESC Board Meeting Date
CESC Ltd scheduled its Board Meeting for 5 Nov 2026 to consider Q2/H1 FY27 unaudited results. No financial figures or decisions are reported in this advance intimation.
Genpharmasec Board Meeting Date
Genpharmasec Ltd will hold a Board meeting on 03 Nov 2026. Agenda includes proposing approval of Q2/H1 FY27 unaudited results.
Hexa Tradex Board Meeting Date
Hexa Tradex scheduled its board meeting for November 5, 2026, to approve Q2 FY27 unaudited financial results. Trading window closes until 48 hours post-disclosure.
Ampvolts Board Meeting Date
Ampvolts Ltd has scheduled its Board meeting for November 6, 2026, to approve unaudited Q2/H1 FY27 results. No financial figures are disclosed in this prior intimation.